{"entity":{"type":"insider","cik":"0001611024","url":"/insider/0001611024","json_url":"/insider/0001611024.json","name":"Chang David D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":20,"first":"2015-06-17","last":"2026-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Chang David D","source":"filing","n_filings":20,"first_seen":"2015-06-17","last_seen":"2026-03-18"}],"transactions":[{"id":5767399,"accession":"0001737287-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-26-000013","line_url":"/filing/0001737287-26-000013#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47763.0,"shares_display":"47,763","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":117974.61,"total_display":"117,974.61","total_whole":"117,975","shares_owned_after":5150599.0,"shares_owned_after_display":"5,150,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider"},{"id":6199374,"accession":"0001737287-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-26-000009","line_url":"/filing/0001737287-26-000009#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95269.0,"shares_display":"95,269","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":171484.2,"total_display":"171,484.20","total_whole":"171,484","shares_owned_after":5185862.0,"shares_owned_after_display":"5,185,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4508332,"accession":"0001737287-25-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000042","line_url":"/filing/0001737287-25-000042#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46668.0,"shares_display":"46,668","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":91469.28,"total_display":"91,469.28","total_whole":"91,469","shares_owned_after":5276569.0,"shares_owned_after_display":"5,276,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":4743766,"accession":"0001737287-25-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001737287-25-000017","line_url":"/filing/0001737287-25-000017#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46003.0,"shares_display":"46,003","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":77285.04,"total_display":"77,285.04","total_whole":"77,285","shares_owned_after":5317237.0,"shares_owned_after_display":"5,317,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":6436192,"accession":"0001214659-22-004085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-004085","line_url":"/filing/0001214659-22-004085#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23648.0,"shares_display":"23,648","price_per_share":7.6488,"price_display":"7.65","price_state":"stated","total_value":180878.8224,"total_display":"180,878.82","total_whole":"180,879","shares_owned_after":2289652.0,"shares_owned_after_display":"2,289,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":4748249,"accession":"0001214659-21-003240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-21-003240","line_url":"/filing/0001214659-21-003240#line-1","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20513.0,"shares_display":"20,513","price_per_share":38.5741,"price_display":"38.57","price_state":"stated","total_value":791270.5133,"total_display":"791,270.51","total_whole":"791,271","shares_owned_after":2204417.0,"shares_owned_after_display":"2,204,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":3020707,"accession":"0001214659-20-002734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-002734","line_url":"/filing/0001214659-20-002734","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20335.0,"shares_display":"20,335","price_per_share":19.307363265306122,"price_display":"19.31","price_state":"stated","total_value":392615.232,"total_display":"392,615.23","total_whole":"392,615","shares_owned_after":2215426.0,"shares_owned_after_display":"2,215,426","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider","n_lines":2},{"id":6609211,"accession":"0001209191-18-055374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-055374","line_url":"/filing/0001209191-18-055374#line-2","is_derivative":false,"issuer_cik":"0001611024","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001611024","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":720000.0,"total_display":"720,000.00","total_whole":"720,000","shares_owned_after":1995625.0,"shares_owned_after_display":"1,995,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-17","scope":"insider"},{"id":5038168,"accession":"0001209191-17-054196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-054196","line_url":"/filing/0001209191-17-054196#line-2","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7927.0,"shares_display":"7,927","price_per_share":179.6639,"price_display":"179.66","price_state":"stated","total_value":1424195.7353,"total_display":"1,424,195.74","total_whole":"1,424,196","shares_owned_after":57423.0,"shares_owned_after_display":"57,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":5118572,"accession":"0001209191-17-029753","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-029753","line_url":"/filing/0001209191-17-029753","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":82.08719,"price_display":"82.09","price_state":"stated","total_value":1641743.8,"total_display":"1,641,743.80","total_whole":"1,641,744","shares_owned_after":56370.0,"shares_owned_after_display":"56,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider","n_lines":3},{"id":5118100,"accession":"0001209191-17-024746","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-024746","line_url":"/filing/0001209191-17-024746","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":81.543278,"price_display":"81.54","price_state":"stated","total_value":1630865.56,"total_display":"1,630,865.56","total_whole":"1,630,866","shares_owned_after":50865.0,"shares_owned_after_display":"50,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-04","scope":"insider","n_lines":6},{"id":4645937,"accession":"0000899243-17-005893","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-005893","line_url":"/filing/0000899243-17-005893","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":79.15735,"price_display":"79.16","price_state":"stated","total_value":4749441.0,"total_display":"4,749,441.00","total_whole":"4,749,441","shares_owned_after":54900.0,"shares_owned_after_display":"54,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-02","scope":"insider","n_lines":2},{"id":3327230,"accession":"0001209191-16-156547","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156547","line_url":"/filing/0001209191-16-156547#line-1","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1788.0,"shares_display":"1,788","price_per_share":50.86,"price_display":"50.86","price_state":"stated","total_value":90937.68,"total_display":"90,937.68","total_whole":"90,938","shares_owned_after":25123.0,"shares_owned_after_display":"25,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-20","filed_date":"2016-12-22","scope":"insider"},{"id":8849409,"accession":"0001209191-15-079843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-079843","line_url":"/filing/0001209191-15-079843#line-2","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30800.0,"shares_display":"30,800","price_per_share":80.02,"price_display":"80.02","price_state":"stated","total_value":2464616.0,"total_display":"2,464,616.00","total_whole":"2,464,616","shares_owned_after":6904.0,"shares_owned_after_display":"6,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-10","filed_date":"2015-11-12","scope":"insider"},{"id":8084376,"accession":"0001209191-15-078540","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-078540","line_url":"/filing/0001209191-15-078540","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":71.07686883116884,"price_display":"71.08","price_state":"stated","total_value":547291.89,"total_display":"547,291.89","total_whole":"547,292","shares_owned_after":6904.0,"shares_owned_after_display":"6,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":4},{"id":8676446,"accession":"0001209191-15-073539","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-073539","line_url":"/filing/0001209191-15-073539#line-2","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":55.11,"price_display":"55.11","price_state":"stated","total_value":424347.0,"total_display":"424,347.00","total_whole":"424,347","shares_owned_after":6904.0,"shares_owned_after_display":"6,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-02","scope":"insider"},{"id":8083670,"accession":"0001209191-15-069828","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-069828","line_url":"/filing/0001209191-15-069828#line-4","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7384.0,"shares_display":"7,384","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":406120.0,"total_display":"406,120.00","total_whole":"406,120","shares_owned_after":6904.0,"shares_owned_after_display":"6,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-08","scope":"insider"},{"id":8083662,"accession":"0001209191-15-069828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-069828","line_url":"/filing/0001209191-15-069828#line-2","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":316.0,"shares_display":"316","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":17380.0,"total_display":"17,380.00","total_whole":"17,380","shares_owned_after":6904.0,"shares_owned_after_display":"6,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-03","filed_date":"2015-09-08","scope":"insider"},{"id":8786050,"accession":"0001209191-15-063816","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-063816","line_url":"/filing/0001209191-15-063816","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":72.10937922077922,"price_display":"72.11","price_state":"stated","total_value":555242.22,"total_display":"555,242.22","total_whole":"555,242","shares_owned_after":10800.0,"shares_owned_after_display":"10,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-04","scope":"insider","n_lines":4},{"id":8578297,"accession":"0001209191-15-059224","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-059224","line_url":"/filing/0001209191-15-059224","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":61.919553246753246,"price_display":"61.92","price_state":"stated","total_value":476780.56,"total_display":"476,780.56","total_whole":"476,781","shares_owned_after":10306.0,"shares_owned_after_display":"10,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-02","scope":"insider","n_lines":3},{"id":8648256,"accession":"0001209191-15-054394","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-054394","line_url":"/filing/0001209191-15-054394","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":56.98032597402597,"price_display":"56.98","price_state":"stated","total_value":438748.51,"total_display":"438,748.51","total_whole":"438,749","shares_owned_after":8541.0,"shares_owned_after_display":"8,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider","n_lines":3},{"id":8648249,"accession":"0001209191-15-054394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-054394","line_url":"/filing/0001209191-15-054394#line-1","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001611024","owner_name":"Chang David D","owner_display_name":"Chang David D","owner_url":"/insider/0001611024","role":"Officer (EVP, R&D, Chief Medical Off)","role_mark":"O","role_mark_label":"Officer (EVP, R&D, Chief Medical Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D, Chief Medical Off.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":68000.0,"total_display":"68,000.00","total_whole":"68,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-25","filed_date":"2015-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":39,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2018-10-17","last_seen":"2026-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Officer (EVP, R&D, Chief Medical Off)","n_filings":12,"first_seen":"2015-06-17","last_seen":"2017-09-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001611024","retrieved_at":"2026-08-23T15:00:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}